Bausch Health Companies (BHC) EBIAT (2016 - 2025)
Historic EBIAT for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $181.0 million.
- Bausch Health Companies' EBIAT rose 29673.91% to $181.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.0 million, marking a year-over-year increase of 26553.4%. This contributed to the annual value of -$72.0 million for FY2024, which is 8821.6% up from last year.
- As of Q3 2025, Bausch Health Companies' EBIAT stood at $181.0 million, which was up 29673.91% from $148.0 million recorded in Q2 2025.
- In the past 5 years, Bausch Health Companies' EBIAT registered a high of $403.0 million during Q3 2022, and its lowest value of -$610.0 million during Q1 2021.
- Its 5-year average for EBIAT is -$84.6 million, with a median of -$69.0 million in 2022.
- As far as peak fluctuations go, Bausch Health Companies' EBIAT crashed by 71304.35% in 2022, and later soared by 138000.0% in 2025.
- Bausch Health Companies' EBIAT (Quarter) stood at $69.0 million in 2021, then tumbled by 713.04% to -$423.0 million in 2022, then soared by 88.89% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then soared by 84.69% to $181.0 million in 2025.
- Its EBIAT was $181.0 million in Q3 2025, compared to $148.0 million in Q2 2025 and -$86.0 million in Q1 2025.